JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Diseases of the Nervous System
Interventions
DRUG:
JY231 Injection
Sponsor
Tongji Hospital